Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michelle M. Lockhart"'
Autor:
Gregory Finucane, Arnold Bok, Michelle M. Lockhart, Mark P. Simpson, Adele McMahon, Lorraine Macdonald, Andrew Smith, Barry Snow, Kenneth Martin Taylor, Chris Frampton, Bb Janice Lam, Eoin Mulroy, Patrick Schweder, Benson S Chen
Publikováno v:
Parkinsonism & Related Disorders. 61:88-93
Introduction Regenerative therapies in Parkinson's disease aim to slow neurodegeneration and re-establish damaged neuronal circuitry. Neurotrophins are potent endogenous regulators of neuronal survival, development and regeneration. They represent an
Autor:
Adele McMahon, Chris Frampton, Eoin Mulroy, Benson S Chen, Arnold Bok, Gregory Finucane, Kenneth Martin Taylor, Lorraine Macdonald, Michelle M. Lockhart, Mark Simpson, Patrick Schweder, Barry Snow, B.B. Janice Lam, Andrew Smith
Publikováno v:
Parkinsonismrelated disorders. 82
Introduction In 2019, we published the results of a Phase IIb randomized controlled trial of putaminal encapsulated porcine choroid plexus cell (termed NTCELL®) administration in patients with Parkinson's disease. This study failed to meet its prima
Autor:
Michael Addidle, Michelle M. Lockhart, Peter J. Gilling, Chris Frampton, Rana Reuther, Mark R. Fraundorfer
Publikováno v:
BJU International. 112:69-73
Objective To compare the effectiveness, safety and cost of Tristel Fuse (chlorine dioxide) with Cidex OPA (ortho-phthaldehyde; 1,2–benzenedicarboxaldehyde) in an automated endoscopic reprocessor (AER) for high-level disinfection of flexible cystosc
Autor:
Michael P. Murphy, Kenneth Martin Taylor, Chris Frampton, David Orr, Edward Gane, Geraldine F. Keogh, Robin A.J. Smith, Frank Weilert, Michael K. Gibson, Michelle M. Lockhart
Publikováno v:
Liver International. 30:1019-1026
Background: Increased oxidative stress and subsequent mitochondrial damage are important pathways for liver damage in chronic hepatitis C virus (HCV) infection; consequently, therapies that decrease mitochondrial oxidative damage may improve outcome.
Publikováno v:
Journal of Urology. 187
Publikováno v:
The New Zealand medical journal. 123(1317)
Globally the traditional model of drug development is changing and the large pharmaceutical companies are looking externally for innovative compounds, new technologies and cost-effective drug development services. New Zealand (NZ) can capitalise on i
Autor:
Barry J, Snow, Fiona L, Rolfe, Michelle M, Lockhart, Christopher M, Frampton, John D, O'Sullivan, Victor, Fung, Robin A J, Smith, Michael P, Murphy, Kenneth M, Taylor, Rosemary, Lockie
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 25(11)
Multiple lines of evidence point to mitochondrial oxidative stress as a potential pathogenic cause for Parkinson's disease (PD). MitoQ is a powerful mitochondrial antioxidant. It is absorbed orally and concentrates within mitochondria where it has be
Autor:
Edward J, Gane, Frank, Weilert, David W, Orr, Geraldine F, Keogh, Michael, Gibson, Michelle M, Lockhart, Christopher M, Frampton, Kenneth M, Taylor, Robin A J, Smith, Michael P, Murphy
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 30(7)
Increased oxidative stress and subsequent mitochondrial damage are important pathways for liver damage in chronic hepatitis C virus (HCV) infection; consequently, therapies that decrease mitochondrial oxidative damage may improve outcome. The mitocho
Autor:
Okoh GR; College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, 4811, Australia. godspower.okoh@my.jcu.edu.au., Lockhart M; CSIRO Australian Centre for Disease Preparedness, Geelong, Victoria, 3220, Australia., Grimsey J; CSIRO Australian Centre for Disease Preparedness, Geelong, Victoria, 3220, Australia., Whitmore D; College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, 4811, Australia., Ariel E; College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, 4811, Australia., Butler J; CSIRO Australian Centre for Disease Preparedness, Geelong, Victoria, 3220, Australia., Horwood PF; College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, 4811, Australia. paul.horwood@jcu.edu.au.
Publikováno v:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2023 Jun; Vol. 42 (6), pp. 741-746. Date of Electronic Publication: 2023 Apr 21.
Autor:
Mulroy E; Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK. Electronic address: e.mulroy@ucl.ac.uk., Snow B; Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand. Electronic address: BSnow@adhb.govt.nz., Bok A; Department of Neurosurgery, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand; Centre for Brain Research, University of Auckland, New Zealand. Electronic address: AriB@adhb.govt.nz., Simpson M; Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand. Electronic address: MarkS@adhb.govt.nz., Smith A; Department of Radiology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand. Electronic address: Asmith@adhb.govt.nz., Taylor KM; Living Cell Technologies New Zealand Limited, PO Box 23566, Hunters Corner, Auckland, 2155, New Zealand. Electronic address: ktaylor@lctglobal.com., Lockhart M; Living Cell Technologies New Zealand Limited, PO Box 23566, Hunters Corner, Auckland, 2155, New Zealand. Electronic address: michellelockhart@xtra.co.nz., Lam BBJ; Living Cell Technologies New Zealand Limited, PO Box 23566, Hunters Corner, Auckland, 2155, New Zealand. Electronic address: jlam@lctglobal.com., Frampton C; Department of Medicine, University of Otago, Christchurch, PO Box 4345, Christchurch, New Zealand. Electronic address: Chris.frampton@otago.ac.nz., Finucane G; Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand. Electronic address: greg@neuropsychiatry.co.nz., Schweder P; Department of Neurosurgery, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand; Centre for Brain Research, University of Auckland, New Zealand. Electronic address: PatrickS@adhb.govt.nz., Chen B; Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand. Electronic address: BensonC@adhb.govt.nz., McMahon A; Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand. Electronic address: AdeleMcM@adhb.govt.nz., Macdonald L; Department of Neurology, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand. Electronic address: LorrMacd@adhb.govt.nz.
Publikováno v:
Parkinsonism & related disorders [Parkinsonism Relat Disord] 2021 Jan; Vol. 82, pp. 128-132. Date of Electronic Publication: 2020 Dec 10.